KLOW (80 mg) | Advanced Peptide Blend: GHK-Cu, BPC-157, TB-500 & KPV | COA Verified

KLOW is an advanced multi‑peptide research blend that combines four well‑studied peptides into a single formulation designed to support comprehensive cellular recovery, tissue repair, regeneration, and inflammation modulation in laboratory and experimental settings. (Physique Pharma)

This composite peptide formula integrates: BPC‑157, TB‑500 (Thymosin Beta‑4 fragment), GHK‑Cu (Copper Peptide), and KPV (Lys‑Pro‑Val tripeptide) — each contributing distinct mechanisms of action for multifunctional biological research pathways. (Physique Pharma)

⚠️ KLOW Peptide Blend is intended for research and educational purposes only.

Product Highlights

✔ Multi‑peptide synergistic blend (BPC‑157 + TB‑500 + GHK‑Cu + KPV) (Physique Pharma)
✔ High‑purity research‑grade formulation (typically ≥98 % purity) (Atlas Compounds)
✔ Lyophilized (freeze‑dried) powder for stability and long shelf‑life (Physique Pharma)
✔ Designed for laboratory exploration of regeneration and inflammation pathways (Transparent Peptides)
✔ Combines tissue repair, collagen synthesis, anti‑inflammatory, and regenerative signaling (Alpha Peptides Info)
✔ Supports controlled in vitro or ex vivo experimental research (Transparent Peptides)
✔ Compatible with reconstitution using bacteriostatic water under aseptic lab protocols (Peptora)

Component Breakdown

1. BPC‑157 – Investigated for cell migration, soft tissue repair, and anti‑inflammatory responses. (Physique Pharma)

2. TB‑500 (Thymosin Beta‑4 fragment) – Explored for actin modulation, angiogenesis, and deeper tissue remodeling. (Transparent Peptides)

3. GHK‑Cu – Studied in skin health, collagen synthesis, extracellular matrix support, and antioxidant pathways. (Physique Pharma)

4. KPV (Lys‑Pro‑Val) – Research highlights anti‑inflammatory signaling and immunomodulation. (Physique Pharma)